Sort   by:  
 Page size 
UnknownEfficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study.
Not available
S-EPMC7069936 | biostudies-literature
UnknownFLU-v, a Broad-Spectrum Peptide-Based Influenza Vaccine, Induces NK Cell Activating IgG1 and IgG3 Subclass Antibodies in Humans.
Not available
S-EPMC12656455 | biostudies-literature
UnknownFLU-v, a Broad-Spectrum Influenza Vaccine, Induces Cross-Reactive Cellular Immune Responses in Humans Measured by Dual IFN-γ and Granzyme B ELISpot Assay.
Not available
S-EPMC9505334 | biostudies-literature
UnknownSafety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial.
Not available
S-EPMC9700263 | biostudies-literature
UnknownAGS-v PLUS, a Mosquito Salivary Peptide Vaccine, Modulates the Response to <i>Aedes</i> Mosquito Bites in Humans.
Not available
S-EPMC12567680 | biostudies-literature
UnknownEvaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial.
Not available
S-EPMC5379643 | biostudies-literature
UnknownA Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans.
Not available
S-EPMC4478518 | biostudies-literature
UnknownMeta-Analysis and Potential Role of Preexisting Heterosubtypic Cellular Immunity Based on Variations in Disease Severity Outcomes for Influenza Live Viral Challenges in Humans.
Not available
S-EPMC4519729 | biostudies-literature
UnknownImpact of a Teledermatology-Based Referral Model on Melanoma Diagnostic Pathways and Clinicopathologic Features: A Retrospective Comparative Study Between Face-to-Face Consultation (2019) and Teledermatology (2022) in a Tertiary Hospital.
Not available
S-EPMC12786944 | biostudies-literature
UnknownSafety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial.
Not available
S-EPMC9151349 | biostudies-literature
Sort   by:  
 Page size